ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
We break down expense ratios across popular index funds and show how choosing the lowest-cost options can improve long-term retirement outcomes.
28,023 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
A surprise cameo sparks conversations about branding, timing, and money. See how a moment like prince william surpris...
ARTY posted a 12-month gain of 28.3%, topping QQQ's 14.3% and SPY's 13.7%, as AI infrastructure exposure draws buyers...
XLY relies heavily on two megacaps, exposing the fund to outsized moves from Amazon and Tesla and prompting renewed q...
Fidelity Enhanced International ETF (FENI) continues to pay a quarterly dividend funded by profits from more than 350...
A dominant market infrastructure firm sits at the heart of capital markets, wielding a legally protected financial mo...
A real-world move shows an investment advisor trims small-cap exposure by millions, signaling risk management and str...
Brookfield is quietly expanding its private debt platform, aiming to become a major player in private credit. This ar...
A new class of buffer ETFs promises protection for the first 15% of losses while chasing stock gains without stress? ...
The (onon) 2026 earnings call offers critical clues about growth drivers, margin reset, and next steps for investors....
A fresh look at AI investing shows the most dramatic gains might come from broad market value and international stock...
Rem’s Mortgage REIT Portfolio surged 19% over the past year as the Fed signaled a slower stance on rates, lifting inc...